Ryosuke Sato

9PUBLICATIONS
17CO-AUTHORS
Molecular targetsInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 10, 2026
Peptide-Reactive T-cell Response as a Novel Biomarker in Patients with Head and Neck Cancer Treated with Anti-PD-1 Antibody.

|Mar 14, 2026
Bovine Lactoferrin Modulates Mononuclear Cell Activity in Human Palatine Tonsils.

Takumi Yago, Chisane Kujirai, Hirotsugu Oda

|Jul 29, 2025
ROR1 as an Immunotherapeutic Target for Inducing Antitumor Helper T Cell Responses Against Head and Neck Squamous Cell Carcinoma.

Ryosuke Sato, Hidekiyo Yamaki, Takahiro Inoue

|Sep 14, 2024
Hypoxia-Targeted Immunotherapy with PD-1 Blockade in Head and Neck Cancer.

Risa Wakisaka, Hidekiyo Yamaki, Michihisa Kono

|Jun 18, 2024
A comparison of the clinical efficacy of tonsillectomy with steroid pulse therapy and tonsillectomy therapy alone for patients with immunoglobulin A nephropathy: a retrospective observational study.

Ryosuke Sato, Risa Wakisaka, Hiroki Komatsuda

|Mar 28, 2024
Exploring Immunological Effects and Novel Immune Adjuvants in Immunotherapy for Salivary Gland Cancers.

Ryosuke Sato, Hidekiyo Yamaki, Hiroki Komatsuda

Pageof 2

Frequent Collaborators

7 joint publications

Takumi Kumai

6 joint publications

Hiroki Komatsuda

5 joint publications

Michihisa Kono

4 joint publications

Kenzo Ohara